AMENDMENT TO WARRANT 



        THIS
AMENDMENT TO WARRANT (this “Amendment”) is made and entered into as of
November 7, 2006 by and between Auriga Laboratories, Inc., a Delaware corporation (the
“Company”), and Christopher S. Walton, an individual (the “Holder”). 



RECITALS 



        WHEREAS,
the Company issued to the Holder a warrant dated July 6, 2006 (the “Warrant”) to
purchase common stock of Multi-Link Telecommunications, Inc., which is the predecessor
entity to the Company, pursuant to which the Holder may purchase from the Company up to
2,000,000 shares of common stock of the Company. 



        WHEREAS,
the Company and the Holder desire to modify and amend the Warrant in accordance with the
terms set forth herein. 



        WHEREAS,
Section 14 of the Warrant provides that the Warrant may be amended by the written
agreement of the Company and the Holder. 



AGREEMENT 



        NOW
THEREFORE, in consideration of the foregoing and the respective covenants and
agreements hereinafter set forth, and intending to be legally bound hereby, the parties
hereto agree as follows: 



        1.              The
preamble to the Warrant shall be deleted in its entirety and the following
          shall be substituted therefor:  




“THE SECURITIES REPRESENTED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN
ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO
THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. 



     



Number of Shares:
2,000,000
Date of Issuance: July 6, 2006 



AURIGA LABORATORIES,
INC. 



Common Stock Warrant 



        Auriga
Laboratories, Inc., and its successors and assigns (the “Company”), for
value received, hereby certifies that Christopher S. Walton, or his registered assigns
(the “Registered Holder”), is entitled, subject to the terms set forth
below, to purchase from the Company, at any time after the date hereof and on or before
the Expiration Date (as defined in Section 6 below), up to 2,000,000 (subject to vesting
and as adjusted from time to time pursuant to the provisions of this Warrant) of Common
Stock of the Company, at a purchase price (as defined in Section 1 below). The shares
purchasable upon exercise of this Warrant and the purchase price per share, as adjusted
from time to time pursuant to the provisions of this Warrant, are sometimes hereinafter
referred to as the “Warrant Shares” and the “Purchase
Price,” respectively.” 













        2.              Section
1 of the Warrant shall be deleted in its entirety and the following           shall be
substituted therefor:  




          		    “1.       
               Purchase Price. The exercise price (the “Purchase
               Price”) shall be equal to the current fair market value per share of
               the Company’s Common Stock of $1.38, subject to adjustment as provided in
               this Warrant.” 



               



        3.              From
and after the date of this Amendment, the references in the Warrant to           “this
Warrant,” “hereof,” “hereunder” or words of           like
import shall be deemed to mean the Warrant as modified and amended by this
          Amendment.  




        4.              Defined
terms used and not defined in this Amendment shall have the same           meanings
assigned to them in the Warrant.  




        5.              Except
as expressly modified and amended pursuant to this Amendment, all of the           terms
and provisions of the Warrant shall remain in full force and effect.  




        6.              This
Amendment may be executed in one or more counterparts, each of which shall           be
deemed an original, but all of which together shall constitute one and the           same
instrument.  




        7.              This
Amendment shall be construed in accordance with and governed by the laws of           the
State of Delaware without regard to choice of law principles.  




        8.              BY
SIGNING THIS AMENDMENT, THE HOLDER WILL BE SUBJECT TO CERTAIN FEDERAL AND           STATE
TAX CONSEQUENCES. THE HOLDER SHOULD CONSULT A TAX ADVISER BEFORE EXECUTING           THIS
AMENDMENT.  






[Remainder of this
page intentionally left blank.]  







-2- 










        IN
WITNESS WHEREOF, the parties have executed this Amendment as of the date and year
first above written. 



		
	AURIGA LABORATORIES, INC.	CHRISTOPHER S. WALTON
	

By: /s/ Philip S. Pesin	/s/ Christopher S. Walton
	Name: Philip S. Pesin	
	Title: Chief Executive Officer	















-3-